Company profile: Newcells Biotech
1.1 - Company Overview
Company description
- Provider of induced pluripotent stem cells (iPSCs) and their differentiated, reliable and reproducible cell and tissue types to support drug discovery, pre-clinical development, and disease mechanism investigation, including a physiologically relevant human small airway epithelial cell model that uses an air-liquid interface for research and drug discovery.
Products and services
- Induced Pluripotent Stem Cell Production: Engineers and produces induced pluripotent stem cells for drug discovery, pre-clinical development and disease mechanism investigation, delivering best quality cells using an iPSC-based approach
- Differentiation into Reliable and Reproducible Cell and Tissue Types: Differentiates iPSCs into reliable, reproducible cell and tissue types for drug discovery, pre-clinical development and disease mechanism investigation, iPSC-derived
- Human Small Airway Epithelial Cell Model: Constructs a physiologically relevant small airway epithelial model using an air-liquid interface to enable research and drug discovery, air-liquid-interface-based.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Newcells Biotech
LifeMine Therapeutics
HQ: United States
Website
- Description: Provider of genomics-, AI-, and synthetic biology-enabled drug discovery and development leveraging evolutionary insights from fungi. Offerings include Top-Down Drug Discovery and Avatar-Rx platforms, the LifeBank collection of 100,000 deep-sequenced wild-type fungi spanning over 25,000 species, pipeline programs such as LIFE-001 for transplantation and an anti-fungal portfolio, plus a GSK alliance to identify novel small-molecule leads for multiple disease areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeMine Therapeutics company profile →
SAW Instruments
HQ: Germany
Website
- Description: Provider of innovative analytical systems for the life sciences market, enabling label-free analysis of molecular biomolecular interactions and combining stability, ease of use, and high sensitivity; develops, manufactures, and sells equipment for life sciences applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SAW Instruments company profile →
Nabsys
HQ: United States
Website
- Description: Provider of semiconductor-based tools for genomic analysis leveraging solid-state, single-molecule positional sequencing and electronic high-definition mapping to analyze entire genomes and structural variants. Offerings include the OhmX Analyzer, Human Chromosome Explorer software, OhmX Sample Prep Kit, OhmX-8 Detector, OhmX Cartridges, and electronic genome mapping via solid-state nanodetectors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nabsys company profile →
Nortis Bio
HQ: United States
Website
- Description: Provider of organ-on-a-chip systems and tissue-engineering techniques that create human micro-tissue environments within small, disposable microfluidic chips, enabling living models of human organs to accelerate discovery and help scientists better understand the causes of human diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nortis Bio company profile →
Pepscan
HQ: The Netherlands
Website
- Description: Provider of peptide R&D and production services, employing protein mimicry techniques and patented technologies. Offerings include peptide libraries, CLIPS technology, personalized neoantigen peptide pools, epitope mapping, and custom peptide synthesis with modifications, plus phage display and lead optimization at an end-to-end facility in Lelystad, the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pepscan company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Newcells Biotech
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Newcells Biotech
2.2 - Growth funds investing in similar companies to Newcells Biotech
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Newcells Biotech
4.2 - Public trading comparable groups for Newcells Biotech
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →